Skip to main content

J&J To Be Sole Responsible In Talc Punitive Damages Trial

J&J To Be Sole Responsible In Talc Punitive Damages Trial

J&J To Be Sole Responsible In Talc Punitive Damages Trial

Introduction

Johnson & Johnson (J&J) will face a new trial on the issue of punitive damages, following the $12 million awarded in compensatory damages to a plaintiff on June 12, who was diagnosed with mesothelioma due to exposure to talcum powder. Recently, Judge Frank Roesch rejected the request from J&J to involve Colgate and Avon in punitive damages.

During a hearing in Oakland, California, the judge set July 8 for the opening argument and rejected J&J's request to wait until it has filed an expedited appeal. Also, the judge rejected J&J's argument that the new jury should be told about the decision from the previous jurors that J&J and Colgate-Palmolive, both were at 40% fault, with the remaining 20% against Avon, which made up the compensatory verdict. The woman's case was given trial preference because she is dying of mesothelioma, and ordered jury selection to begin as soon as possible.

J&J is facing nearly 14,000 talcum powder lawsuits, each raising a common allegation that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma. Hon. Freda L. Wolfson, U.S.D.J., and Hon. Lois H. Goodman, U.S.M.J., is presiding over all J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!